a. "Electroclinical": clinical phenomena are associated with corresponding seizure activity on electroencephalography (EEG), e.g., clonic seizures.
b. "Electrographic only" (sub-clinical/occult seizure): EEG abnormalities are not associated with any definite clinical seizure activity.
The above two categories respond to antiepileptic drugs (AED) and are often associated with autonomic changes such as tachycardia and mild elevation of blood pressure.
c. "Clinical only": Abnormal clinical events are not associated with EEG changes. Occur spontaneously or after stimulation and can often be suppressed or altered by restraining or repositioning the baby. There is no autonomic phenomenon, do not respond to AED. The first step would be to exclude non-epileptic event like jitteriness, benign sleep myoclonus and to differentiate between benign neonatal seizure groups from malignant epileptic syndromes.
Causes of Neonatal Seizures
Non-epileptic seizure events during neonatal period 1-8 : i. Jitteriness is due to cerebral excitability and usually mimics clonic seizure.
Causes: Physiological, idiopathic, perinatal asphyxia, hypoglycaemia, hypocalcaemia, polycythaemia, drug withdrawal etc.
Symmetrical tremors of extremities which are stopped by grasping the hand or passive flexion of limbs, aggravates by touching.
Rate of tremor is identical in either direction (whereas in clonic seizures there is a rapid alteration of fast and slow phase of movement).
Eye movements are normal (staring, blinking, nystagmoid jerks or tonic horizontal eye deviation occurs during seizure but absent in jitteriness).
ii. Benign neonatal sleep myoclonus: The mechanism for such nonepileptiform myoclonus is unclear but may be related to a transient dysmaturity of the brainstem reticular-activating system. Presents in the first week of life. Always occur during sleep, rapidly abolished by arousal, never occur during wakefulness.
Precipitated by gentle rhythmic rocking or tactile stimuli. Preictal, ictal and post-ictal EEG is normal. Anticonvulsants are not indicated, rather benzodiazepam exacerbate myoclonic jerks.Resolves spontaneously over weeks to months. Long-term outcome is good and epilepsy does not develop later.
The benign neonatal seizure group includes benign familial neonatal convulsion and benign neonatal convulsion ( Table-I ).
The malignant group includes early infantile epileptic encephalopathy (Ohtahara's syndrome) and early myoclonic encephalopathy. Both these groups are differentiated from commonly occurring neonatal seizure by their characteristic clinical features and EEG changes (Table-II) .
Treatment:
The decision to initiate antiepileptic drug therapy should be based on consideration of several factors like etiology and nature of seizure. Usually all abnormal paroxysmal clinical events in the newborn are considered as seizures and therefore neonatal seizures are over treated in an attempt to abolish all evidence of seizure activity 5 . But only epileptic seizures are to be treated. Epileptic seizures in addition to their classical presentations are associated with EEG changes and autonomic disturbances like alterations in heart rate, blood pressure, respiration, salivation, flushing, pupillary dilatations etc [1] [2] [3] . When epileptic seizures are of long durations (longer than one minute) and occur frequently (more than two in one hour) should be treated vigorously with antiepileptic drugs 4, 5 .
Electroclinical dissociation (state where clinical seizures disappears but EEG evidence persists after treatment) is common in neonatal seizure and the persistence of such electrographic seizure adversely affect subsequent developmental outcome 9, 10 . To overcome this problem continuous digital video EEG monitoring has been advocated for management of such electrographic seizure. This facility is not available in most developing countries, keeping this view in mind, treatment strategies are outlined here. To correct hypoglycemia 10% glucose in water 2 ml/kg bolus is followed by continuous infusion at up to 8 mg/kg/min. To treat hypocalcemia IV calcium gluconate 10% 2ml/kg over 10 minutes with cardiac rhythm monitoring and 8 ml /kg/day is given as maintenance therapy. Hypomagnesemia is treated with 50% solution of magnesium in a dose of 0.2 ml/ kg. The rest of the symptomatic seizures (nonmetabolic) are treated with phenobarbitone (PB). If seizures failed to respond or recurs after PB therapy, phenytoin (PHT) should be given 10, 11 ( Fig.-1) .
If seizures are still intractable (not responding to maximum loading doses of PB and PHT, continuous intravenous drip of either lidocaine or midazolam has been suggested. A trend for lidocaine to be more effective in reducing seizure burden was noted compared to midazolam 11 . Lidocaine has been extensively used in Europe whereas midazolam has been practiced in USA and UK.PB and PHT are equally effective in controlling seizure in less than 50% cases. The efficacy is increased to 60% when PHT was added to PB 4 . Lidocaine drip can be started with a loading dose of 2 mg/Kg given over 20 minutes followed by 4-6 mg/kg/hr in continuous drips. Midazolam can be started with an infusion rate 60-200 µg/kg/hr but very high doses up to 1000 µg/kg/ hr had been used to control drug resistant neonatal seizure 11, 12 .
Diazepam (0.25-0.35 mg/kg IV or 0.5 mg/kg/rectal) has a very long half-life in babies (approximately 30-75 hours); because of the respiratory depressant effect diazepam is not suitable for prolonged infusions. Experience with lorazepam in newborn is limited 1 . Clonazepam causes increased salivation and bronchial secretion. Other agents given orally to control medically refractory seizures include carbamazepine, valproate, vigabatrin and lamotrigine; but their use in neonates is very much rare. Topiramate is also found to be effective and of less toxic but still are not in common practice 1, 2 .
Once seizure control become difficult with above regimen, appropriate aetiological search should be made which commonly includes exclusion of pyridoxine related seizures(a therapeutic trial of iv 50-100 mg of pyridoxine followed by remission of seizures and normalization of EEG), folinic acid deficiency ( a course of folinic acid 2.5 mg twice a day, increasing the dose up to 8 mg/kg/day may be required) and rare metabolic disorders 1, 12 ( Fig-1) .
Maintenance therapy: The use of long-term antiepileptic drug (AED) as maintenance therapy for neonates after the acute seizures have been controlled, is not well standardized. There is no consensus guideline regarding optimum duration of long term treatment and type of AED 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] . Elimenation rates are particularly slow in asphyxiated infants where there is hepatic and renal involvement. However, elimination rates do increase with duration of therapy and dose may increase during maintenance therapy.
The maintenance is begun 12 hours after the loading dose. Phenobarbitone can be given IV/IM or per oral in two divided doses (12 hourly). Drug accumulation results within 5-10 days with a maintenance dose of 5 mg/kg/day. This effect may depress the infant significantly and relates to slow increase. Recent studies have shown increased apoptotic neurodegeneration in the developing rat brain after exposure to phenobarbitone, phenytoin and benzodizepines 16,17,19,23 . As phenobarbitone causes apoptosis, inhibits brain growth, impairs cognition and behviour, it should be used for the shortest time possible 24, 25 .
Phenytoin should be given only by intravenous route. Intramuscular administration of phenytion can cause muscle necrosis. But fosphenytoin can be given IM or IV 1,2 . Oral administration of phenytoin is less reliable because of poor absorption. Maintenance administration of phenytoin in newborn is particularly difficult because of nonlinear kinetics and rapid decrease in elimination rates in the first weeks of life. Careful attention to levels is especially necessary when this drug is used for maintenance 18, 19, 22 .
Duration of Therapy: Optimal duration of therapy is determined by underlying aetiology, recurrence rate, neurological status and EEG changes 18, 19 . As the recurrence rate is relatively small and the potential toxicities are high on developing brain, the good practice is to stop anticonvulsant as early as possible. The common practice is to withdraw anticonvulsants before discharge home if the baby is neurologically normal on examination. Babies who are discharged home on anticonvulsant treatment, withdrawal is undertaken at the earliest opportunity when clinical neurological recovery occurs. In persistently neurologically abnormal infants, anticonvulsants may be continued for upto six months but an attempt should be made to withdraw phenobarbitone by that time, and, if seizure recurs, other appropriate anticonvulsant such as carbamazepine, topiramate and levetiracetam should be introduced.If a child receives AED for longer time, it should be tapered off gradually over 6 weeks [1] [2] [3] 18, 19 ( Fig-2) .
Prognosis
Neonatal seizures have an adverse effect on neurodevelopmental outcome and predispose to cognitive, behavioral, or epileptic complications in later life 18, 19 with etiology; seizures due to sub arachnoid haemorrhage and late onset hypocalcaemia carry a relatively good prognosis than seizures due to hypoglycemia, cerebral malformations and meningitis [1] [2] [3] . The overall incidence of subsequent epilepsy is around 10-20% and two thirds of the recurrences occur within first six months of life 18,19,25, .
Conclusion
Immature brain of neonates is more epileptogenic than mature brain and seizure-induced injury to developing brain may lead to serious and significant problem 20 . So proper care is crucial. Controversies regarding drug choice have emerged. Electroencephalography remains the most useful investigation for diagnosis and prognosis. The search 
